U.S. FDA Says HCQ & Other Malaria Drugs in Shortage as COVID-19 Drives Up Demand
Roche Gets FDA Nod for Trial to Test Arthritis Drug on COVID-19 Patients
FDA Advisory Committees Reject Oxycodegol (NKTR-181) Application
FDA Rheumatology Update: New Drug Approvals, Plus Expanded Drug Indications & Safety Concerns
New Gabapentinoid Warning Labels
FDA Action on Loperamide Misuse; Plus Phase 1 Trials for BAT2506 Biosimilar Begin
Trump Nominates MD Anderson Oncologist as U.S. FDA Commissioner
FDA Approves Ixekizumab for Treating Active Ankylosing Spondylitis
FDA Approves the Biosimilar Hadlima (Adalimumab-bwwd)
- 1
- 2
- 3
- …
- 24
- Next Page »